Skip to main content
Premium Trial:

Request an Annual Quote

NYS Department of Health Allows Clinical Genomics to Offer Colorectal Cancer Test

NEW YORK — Clinical Genomics said on Monday that New York State Department of Health has issued a permit allowing use of the company's Colvera colorectal cancer liquid biopsy test within New York state.

Colvera is now available in all 50 US states, Clinical Genomics said.

Colvera detects aberrant methylation in BCAT1 and IKZF1, two genes found at a high frequency in colorectal cancer tissue. Identification of the biomarkers can help in the management of patients previously treated for colorectal cancer who are undergoing follow-up testing to assess the presence of residual or recurrent disease.

In November, Bridgewater, New Jersey-based Clinical Genomics said that Colvera received Medicare coverage under Medicare Administrative Contractor Novitas Solution's revised local coverage determination. In July, the company's received licensure from California authorities, which allows the test to be offered there.

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.